U.S. Gas Utilities Stock News

Recent analyst reports on Atour Lifestyle Holdings (NasdaqGS:ATAT) have focused on upward revisions to earnings estimates and a Zacks Rank #1. This has drawn fresh attention to the stock within the leisure and recreation services sector. See our latest analysis for Atour Lifestyle Holdings. Atour Lifestyle Holdings has seen short term momentum pick up, with a 12.30% 7 day share price return and 9.31% 30 day share price return, although the share price is still down 11.39% year to date. The 3...

Earlier this week, Baird downgraded Caterpillar after flagging growing U.S. state and local opposition to AI data center development that could slow future demand for its power generation equipment. This reassessment of data center–linked growth comes just as Caterpillar is expanding its role in AI infrastructure and facing fresh regulatory and supply chain questions, including new rare earth export restrictions from Beijing. We’ll now examine how rising regulatory pushback against AI data...

In the past week, uniQure N.V. reported Q2 2026 results showing revenue of US$5.84 million alongside a much larger quarterly net loss of US$81.06 million, while also filing a US$12.83 million shelf registration for 350,000 ordinary shares tied to its employee share plan. At the same time, the company advanced its regulatory plans for AMT-130 in Huntington’s disease and highlighted promising early data in epilepsy and Fabry programs, framing a contrast between widening losses and progress in...

Old Dominion Freight Line (ODFL) just released its second quarter 2026 earnings, giving investors new data on revenue, profitability and capital returns through buybacks and dividends that could reshape how the stock is viewed. See our latest analysis for Old Dominion Freight Line. The latest earnings beat and active capital returns come after a strong run in Old Dominion Freight Line’s stock, with a year to date share price return of 39.95% and a 1 year total shareholder return of 50.25%,...

CrowdStrike Holdings (CRWD) has moved into the spotlight after joining Nvidia and Hugging Face as a founding partner of the Open Secure AI Alliance, following the widely discussed AI-related incident involving OpenAI and Hugging Face. See our latest analysis for CrowdStrike Holdings. CrowdStrike Holdings has seen short term share price pressure, with the 7 day share price return down 4.8% and the 30 day share price return down 3.4%. However, momentum over longer periods remains strong, given...

Textron (TXT) is back in focus after its latest update combined several key signals. The company reported second quarter results, reaffirmed full year 2026 earnings guidance, and confirmed completion of a planned share repurchase tranche. See our latest analysis for Textron. Textron's recent earnings beat, reiterated 2026 guidance and completion of its buyback tranche came as the share price fell 4.8% on the day and 10.7% over 90 days, while the 1 year total shareholder return of 9.8% points...

Recently, Georgia’s governor reaffirmed his push to make the state an EV manufacturing hub despite expiring federal tax credits, backing Rivian’s planned US$5.00 billion factory that secured a US$6.57 billion Department of Energy loan in early 2025, while analysts highlighted Rivian’s stronger delivery outlook, capital raise, and new autonomy partnership with Uber ahead of its upcoming earnings release. These developments underscored how policy support, improved funding access, and growing...

Pacsun and Ulta Beauty have already rolled out an exclusive Pacsun x Ulta Beauty capsule across stores and online, while Ulta has recently backed several category-expanding launches, including plusOne sexual wellness products, Peach & Lily’s “Zombie Cream,” and Ice Spice’s debut fragrance with Revlon. Together, these collaborations and exclusive launches reinforce Ulta Beauty’s role as a key platform where fashion, wellness, science-led skincare, and celebrity-driven products intersect for...

Novanta (NasdaqGS:NOVT) has completed its acquisition of Riverpoint Medical. The deal significantly increases Novanta's exposure to the medical consumables market. Management expects the transaction to approximately double recurring medical consumables revenue. Novanta focuses on precision photonics, vision and motion technologies used in medical and advanced industrial applications. With Riverpoint Medical now under its umbrella, the company gains a larger footprint in medical consumables,...

Owens Corning recently announced that Jonathan Collins will become Executive Vice President and Chief Financial Officer on August 10, 2026, succeeding Todd Fister, who moves into the newly defined role of President and Chief Operating Officer to oversee enterprise initiatives and operational execution. The appointment brings in a finance leader with experience integrating generative AI and managing complex transformations, while freeing Fister to concentrate on aligning operations and...

Why Littelfuse Stock Is Back in Focus After Q2 Results Littelfuse (LFUS) has drawn fresh investor attention after reporting second quarter 2026 earnings, issuing new third quarter sales guidance, and announcing a higher quarterly cash dividend. See our latest analysis for Littelfuse. Littelfuse shares have pulled back recently, with a 1 month share price return of down 8.59% even after a 1 day gain of 4.70% following the Q2 results. The 1 year total shareholder return of 59.21% reflects...

BorgWarner stock has delivered a strong 82.5% return over the past year, yet its valuation signals are split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to a sizeable discount while the broader checks lean expensive. Over the last 12 months, BorgWarner has returned 82.5%, which puts recent price action front and centre in any valuation discussion. New contracts in electrified boosting and drivetrain systems can support expectations for future cash flows. However, the...

In recent commentary, analysts highlighted that Lear Corp remains well positioned in the automotive equipment industry, supported by new program wins, recent acquisitions, and a focus on improving profitability through automation and restructuring initiatives. They also pointed to management’s emphasis on strong free cash flow conversion in 2026 and a favorable analyst ranking, reflecting confidence in the company’s operational plans. An interesting takeaway is how Lear’s push into...

In late July 2026, SS&C Technologies Holdings, Inc. filed a US$779 million shelf registration for 10,000,000 common shares tied to an ESOP-related offering, shortly after reporting second-quarter 2026 revenue of US$1,695.7 million and net income of US$234.8 million, both higher than the prior year. The earnings release also showed higher basic and diluted earnings per share from continuing operations for both the quarter and first half of 2026, pointing to improved profitability alongside...

Eton Pharmaceuticals has submitted a Prior Approval Supplement to the FDA seeking to extend KHINDIVI’s hydrocortisone oral solution label to younger pediatric patients with adrenocortical insufficiency, beyond its current approval for those aged five and older. This move, backed by bioequivalence data versus ALKINDI SPRINKLE, could broaden treatment options in a rare disease population where Eton estimates about 10,000 U.S. pediatric patients. With KHINDIVI already the only FDA-approved...

Cadence Design Systems (CDNS) drew fresh attention after raising its 2026 revenue guidance to a projected 19% year over year growth, supported by strong second quarter AI and high performance computing demand. See our latest analysis for Cadence Design Systems. Even with the upbeat 2026 outlook and new AI collaborations such as the Rapidus partnership, Cadence Design Systems’ recent performance has been mixed, with the share price down 10.72% over 30 days but a 5-year total shareholder return...

Pentair stock has fallen sharply this year, yet the company still screens as undervalued on several key checks, including an intrinsic value estimate that sits well above the current share price. With sentiment hit by legal investigations and weaker trading in parts of the business, investors are weighing whether the current discount fairly reflects the risks now in play. Year to date, Pentair shares are down 36.9%, which means current holders have taken a sizeable hit and new investors are...

In late July 2026, expectations for Amdocs’ June-quarter results pointed to higher year-over-year earnings and revenue, but recent analyst revisions turned more cautious as the most accurate EPS estimate slipped below the broader consensus. This divergence between headline growth expectations and softer short-term earnings sentiment has become a key focus for investors evaluating Amdocs’ near-term outlook. We’ll now examine how this cautious earnings sentiment, despite anticipated growth,...

Flex stock reacts to record quarter and raised 2027 outlook Flex (FLEX) is back in focus after reporting record first quarter fiscal 2027 earnings, lifting full year revenue guidance and confirming plans to separate its Cloud and Power Infrastructure business. See our latest analysis for Flex. The sharp share price pullback after earnings, including a 1-day share price return that declined 9.06% and a 30-day share price return that fell 36.43%, comes after very strong long term momentum, with...

StoneCo (STNE) is back in focus after the stock fell 2.15%, lagging major indexes, as investors look ahead to the company’s August 13, 2026 earnings release. See our latest analysis for StoneCo. The recent 1-day share price return decline of 1.79% and 7-day decline of 3.52% extend a weaker short term trend for StoneCo. At the same time, the 1-year total shareholder return of 2.45% and 5-year total shareholder return decline of 76.58% point to mixed longer term outcomes around the current...

Viridian Therapeutics recently reported positive topline results from its Elegrobart REVEAL-1 phase III trial in Graves' ophthalmopathy and outlined plans to submit a Biologics License Application in early 2027. This progress, combined with the recent approval of Viridian’s LUMVOA and a pipeline that includes other emerging therapies for Graves’ ophthalmopathy, highlights the company’s growing role in this specialized autoimmune eye disease market. We’ll now examine how the positive...

USA Rare Earth, Inc. previously announced that CEO and director Barbara Humpton retired on October 1, 2026, with Serra Verde Group CEO Thrasyvoulos Moraitis set to assume the USA Rare Earth CEO role following the closing of their planned business combination and initially serving as President. At the same time, the board elevated long-time chair Michael Blitzer to Executive Chair with a multi-year, performance-tied equity package, underscoring his central role in shaping the company’s...

Teekay Tankers Ltd. has reported its results for the quarter ended June 30, 2026 and declared a fixed quarterly cash dividend of US$0.25 per share, payable on August 21, 2026 to shareholders of record on August 10, 2026. This combination of a regular dividend payout and fresh quarterly figures gives investors new information on how the business is currently performing and returning cash. Next, we will examine how the latest quarterly earnings and continued US$0.25 dividend shape Teekay...

Fed Chair Kevin Warsh’s move to dial back forward guidance has left markets more data driven and, at times, more jumpy. When rate clues are harder to read, many investors start to focus on stocks that have shown relatively low price swings and steadier profiles. That is where a low volatility screener can help filter the chaos. This article looks at three stocks from that list that appear positively exposed to the current policy uncertainty and recent volatility in Treasury yields, and...